Opko Health, Inc.
OPK
$1.90
$0.010.53%
| Weiss Ratings | OPK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | OPK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | OPK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.92 | |||
| Price History | OPK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 14.46% | |||
| 30-Day Total Return | 27.52% | |||
| 60-Day Total Return | 19.50% | |||
| 90-Day Total Return | 35.71% | |||
| Year to Date Total Return | 31.03% | |||
| 1-Year Total Return | 99.73% | |||
| 2-Year Total Return | 79.25% | |||
| 3-Year Total Return | -39.10% | |||
| 5-Year Total Return | -14.41% | |||
| 52-Week High % Change | -7.13% | |||
| 52-Week Low % Change | 119.74% | |||
| Price | OPK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $2.04 | |||
| 52-Week Low Price | $0.86 | |||
| 52-Week Low Price (Date) | Mar 19, 2024 | |||
| 52-Week High Price (Date) | Mar 05, 2025 | |||
| Valuation | OPK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.27B | |||
| Enterprise Value | 1.34B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.08 | |||
| Earnings Per Share Growth | -68.04% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 2.52 | |||
| Price/Book (Q) | 0.93 | |||
| Enterprise Value/Revenue (TTM) | 1.88 | |||
| Price | $1.90 | |||
| Enterprise Value/EBITDA (TTM) | -7.66 | |||
| Enterprise Value/EBIT | -4.91 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | OPK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 951.84M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | OPK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | (305) 575-4100 | |||
| Address | 4400 Biscayne Boulevard Miami, FL 33137 | |||
| Website | www.opko.com | |||
| Country | United States | |||
| Year Founded | 2007 | |||
| Profitability | OPK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -38.35% | |||
| Profit Margin | -7.46% | |||
| Management Effectiveness | OPK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -8.12% | |||
| Return on Equity | -- | |||
| Income Statement | OPK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 713.14M | |||
| Total Revenue (TTM) | 713.14M | |||
| Revenue Per Share | $0.75 | |||
| Gross Profit (TTM) | 113.30M | |||
| EBITDA (TTM) | -175.38M | |||
| EBIT (TTM) | -273.56M | |||
| Net Income (TTM) | -53.22M | |||
| Net Income Avl. to Common (TTM) | -53.22M | |||
| Total Revenue Growth (Q YOY) | 0.95% | |||
| Earnings Growth (Q YOY) | 121.10% | |||
| EPS Diluted (TTM) | -0.08 | |||
| EPS Diluted Growth (Q YOY) | 119.28% | |||
| Balance Sheet | OPK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 426.58M | |||
| Cash Per Share (Q) | $0.45 | |||
| Total Current Assets (Q) | 662.09M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 1.37B | |||
| Current Ratio (Q) | 3.429 | |||
| Book Value Per Share (Q) | $2.03 | |||
| Total Assets (Q) | 2.20B | |||
| Total Current Liabilities (Q) | 193.10M | |||
| Total Debt (Q) | 501.44M | |||
| Total Liabilities (Q) | 834.76M | |||
| Total Common Equity (Q) | 1.37B | |||
| Cash Flow | OPK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 352.21M | |||
| Cash from Financing (TTM) | 184.17M | |||
| Net Change in Cash (TTM) | 349.73M | |||
| Levered Free Cash Flow (TTM) | -129.55M | |||
| Cash from Operations (TTM) | -183.49M | |||
